Common Stock Alternative Reporting
Pink Current Information
Contact Info
  • 135 Beaver Street
  • Waltham, MA 02452

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Aug 14, 2017
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001037649
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark B. Carbeau CEO
Stephen DiPalma Interim CFO
Company Directors
James M. Weaver Chairman
Mark B. Carbeau
Lionel Carrot
William C Mills III
Joseph M. Landstra
Dayton Misfeldt
Service Providers
Accounting/Auditing Firm
Grant Thornton
226 Causeway Street
Boston, MA, 02114
United States
Securities Counsel
Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, MA, 02111
United States
Investor Relations Firm

Not Available
Company History
  • Note=3-00 State of Incorporation Texas changed to Delaware
  • Formerly=Medical Science Systems, Inc. until 8-99
ILIU Security Details
Share Structure
Market Value1 $1,158,831 a/o Sep 18, 2017
Authorized Shares 650,000,000 a/o Oct 20, 2016
Outstanding Shares 229,471,392 a/o Apr 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 40,865,161 a/o Mar 27, 2016
Par Value 0.001
Transfer Agent(s)
Shareholders of Record 121 a/o Apr 17, 2017
Short Selling Data
Short Interest 253,729 (411.65%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security